It is well established that tafazzin-deficiency alters cardiolipin composition in patients and various experimental models (Joshi et al., 2009; Lu et al., 2016; Pu, 2022). This evidence concerns the gene TAFAZZIN and hyperinsulinemic hypoglycemia, familial, 4.